European Journal of Cancer
Volume 41, Issue 13 , Pages 1941-1954, September 2005

Beer constituents as potential cancer chemopreventive agents

Deutsches Krebsforschungszentrum (DKFZ), Abteilung Toxikologie und Krebsrisikofaktoren, Im Neuenheimer Feld 280, 69120 Heidelberg, Germany

Received 24 March 2005; accepted 1 April 2005.

Abstract 

Beer is a complex alcoholic beverage made from barley (malt), hop, water and yeast. Phenolic constituents of beer are derived from malt (70–80%) and hop (20–30%). Structural classes include simple phenols, benzoic- and cinnamic acid derivatives, coumarins, catechins, di-, tri- and oligomeric proanthocyanidins, (prenylated) chalcones and flavonoids as well as alpha- and iso-alpha-acids derived from hop. Compounds belonging to different structural classes have distinct profiles of biological activity in in vitro test systems, and in combination might lead to enhanced effects. Scientific evidence has accumulated over the past 10 years pointing to the cancer preventive potential of selected hop-derived beer constituents, i.e., prenylflavonoids including xanthohumol and isoxanthohumol, and hop bitter acids. Chemopreventive activities observed with these compounds relevant to inhibition of carcinogenesis at the initiation, promotion and progression phases, as well as results from in vivo studies on metabolism, bioavailability and efficacy are summarised in this review.

Keywords: Beer, Hop (Humulus lupulus L.), Cancer chemoprevention, Xanthohumol, Isoxanthohumol, 8-Prenylnaringenin, Humulone, iso-Alpha-acids, Malt, Epidemiology, Metabolism, Antioxidants

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.
 

PII: S0959-8049(05)00330-8

doi:10.1016/j.ejca.2005.04.012

European Journal of Cancer
Volume 41, Issue 13 , Pages 1941-1954, September 2005